| Insurance Industry | Financials Sector | Mr. Philippe Roussouly CEO | XFRA Exchange | FR0014005I80 ISIN |
| FR Country | 43 Employees | - Last Dividend | - Last Split | - IPO Date |
Founded in 2009 and headquartered in Saint-Priest, France, S.M.A.I.O S.A. is a pioneering company that specializes in developing cutting-edge solutions for spinal pathologies. The company's commitment to innovation is exemplified by its comprehensive portfolio of software, implantable devices, and a broad range of services designed to support surgeons and enhance patient outcomes in spinal surgery procedures. S.M.A.I.O S.A.'s expertise and products are integral to advancing the field of spinal treatment, making it a key player in the global healthcare market.
S.M.A.I.O S.A. offers proprietary software solutions designed to assist surgeons in the planning and execution of spinal surgeries. These tools facilitate precision and efficiency, enabling healthcare professionals to simulate and visualize complex surgical procedures before they are performed. This not only enhances surgical outcomes but also contributes to the safety and recovery of patients.
The company's range of implantable devices includes state-of-the-art products engineered to support, align, or replace parts of the spine affected by pathology. These devices are crafted using advanced materials and techniques to ensure compatibility, durability, and effectiveness. They play a critical role in the restoration of spinal function and the alleviation of pain for patients suffering from a variety of spinal conditions.
Along with its innovative products, S.M.A.I.O S.A. provides a suite of services to support healthcare providers. These services encompass training programs for surgeons, technical support, and patient education resources. By offering these comprehensive services, S.M.A.I.O S.A. ensures that its solutions are implemented effectively and that patients achieve the best possible health outcomes.